These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 20138023)

  • 1. Cell-penetrating peptide exploited syndecans.
    Letoha T; Keller-Pintér A; Kusz E; Kolozsi C; Bozsó Z; Tóth G; Vizler C; Oláh Z; Szilák L
    Biochim Biophys Acta; 2010 Dec; 1798(12):2258-65. PubMed ID: 20138023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of syndecans to lipoplex-mediated gene delivery.
    Letoha T; Kolozsi C; Ekes C; Keller-pintér A; Kusz E; Szakonyi G; Duda E; Szilák L
    Eur J Pharm Sci; 2013 Jul; 49(4):550-5. PubMed ID: 23732629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular interplays involved in the cellular uptake of octaarginine on cell surfaces and the importance of syndecan-4 cytoplasmic V domain for the activation of protein kinase Cα.
    Nakase I; Osaki K; Tanaka G; Utani A; Futaki S
    Biochem Biophys Res Commun; 2014 Apr; 446(4):857-62. PubMed ID: 24632200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a non-cationic cell penetrating peptide derived from membrane-interacting human proteins and its potential as a protein delivery carrier.
    Young Kim H; Young Yum S; Jang G; Ahn DR
    Sci Rep; 2015 Jun; 5():11719. PubMed ID: 26114640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
    Reissmann S
    J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-Surface Interactions on Arginine-Rich Cell-Penetrating Peptides Allow for Multiplex Modes of Internalization.
    Futaki S; Nakase I
    Acc Chem Res; 2017 Oct; 50(10):2449-2456. PubMed ID: 28910080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of novel protein-derived arginine-rich cell-penetrating peptides.
    Gautam A; Sharma M; Vir P; Chaudhary K; Kapoor P; Kumar R; Nath SK; Raghava GP
    Eur J Pharm Biopharm; 2015 Jan; 89():93-106. PubMed ID: 25459448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide-mediated protein delivery-which pathways are penetrable?
    Räägel H; Säälik P; Pooga M
    Biochim Biophys Acta; 2010 Dec; 1798(12):2240-8. PubMed ID: 20170627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-penetrating peptides: possibilities and challenges for drug delivery in vitro and in vivo.
    Skotland T; Iversen TG; Torgersen ML; Sandvig K
    Molecules; 2015 Jul; 20(7):13313-23. PubMed ID: 26205056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
    Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
    Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular internalization kinetics of (luciferin-)cell-penetrating peptide conjugates.
    Eiríksdóttir E; Mäger I; Lehto T; El Andaloussi S; Langel U
    Bioconjug Chem; 2010 Sep; 21(9):1662-72. PubMed ID: 20684543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential uptake of L- versus D-amino acid cell-penetrating peptides in a cell type-dependent manner.
    Verdurmen WP; Bovee-Geurts PH; Wadhwani P; Ulrich AS; Hällbrink M; van Kuppevelt TH; Brock R
    Chem Biol; 2011 Aug; 18(8):1000-10. PubMed ID: 21867915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Current Role of Cell-Penetrating Peptides in Cancer Therapy.
    Feni L; Neundorf I
    Adv Exp Med Biol; 2017; 1030():279-295. PubMed ID: 29081059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of amphiphilic α-helical cell-penetrating peptides with heparan sulfate.
    Yang J; Tsutsumi H; Furuta T; Sakurai M; Mihara H
    Org Biomol Chem; 2014 Jul; 12(26):4673-81. PubMed ID: 24867193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syndecan-4 Mediates the Cellular Entry of Adeno-Associated Virus 9.
    Hudák A; Roach M; Pusztai D; Pettkó-Szandtner A; Letoha A; Szilák L; Azzouz M; Letoha T
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Assays: Friends or Foes of Cell-Penetrating Peptides.
    Liu J; Afshar S
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration without cells: membrane translocation of cell-penetrating peptides in the model giant plasma membrane vesicles.
    Säälik P; Niinep A; Pae J; Hansen M; Lubenets D; Langel Ü; Pooga M
    J Control Release; 2011 Jul; 153(2):117-25. PubMed ID: 21420454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics of cell-penetrating peptides.
    Sarko D; Beijer B; Garcia Boy R; Nothelfer EM; Leotta K; Eisenhut M; Altmann A; Haberkorn U; Mier W
    Mol Pharm; 2010 Dec; 7(6):2224-31. PubMed ID: 20845937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct uptake routes of cell-penetrating peptide conjugates.
    Lundin P; Johansson H; Guterstam P; Holm T; Hansen M; Langel U; EL Andaloussi S
    Bioconjug Chem; 2008 Dec; 19(12):2535-42. PubMed ID: 19012426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syndecan-4 Is a Receptor for Clathrin-Mediated Endocytosis of Arginine-Rich Cell-Penetrating Peptides.
    Kawaguchi Y; Takeuchi T; Kuwata K; Chiba J; Hatanaka Y; Nakase I; Futaki S
    Bioconjug Chem; 2016 Apr; 27(4):1119-30. PubMed ID: 27019270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.